Evidence map›Paper›PMID 27587407›Full record

ArticleCirculation research2016

HDL Particle Size and Functional Heterogeneity.

Sergio Fazio, Nathalie Pamir

Abstract readEditorialComment
In one paragraph

Article in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. βDrug design, development and therapy · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Sergio FazioFrom the Center for Preventive Cardiology of the Knight Cardiovascular Institute, Department of Medicine, Oregon Health & Science University, Portland. fazio@ohsu.edu.
Nathalie PamirFrom the Center for Preventive Cardiology of the Knight Cardiovascular Institute, Department of Medicine, Oregon Health & Science University, Portland.

Funding

FUNCTIONAL HIERARCHY OF REMNANT LIPOPROTEIN RECEPTORSR01HL057986 · NHLBI · VANDERBILT UNIVERSITY · PI FAZIO, SERGIO · 1998 to 2016
$6.2M
NHLBI NIH HHS R01 HL057986
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lipoproteins, HDLParticle SizeBiological TransportCholesterolCholesterol, HDLCholesterolCholesterol, HDLLipoproteins, HDLEditorialsHDL cholesterolHDL functionHDL particle sizereverse cholesterol transportsterol efflux

Identifiers

PMID27587407
PMCPMC5971193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.